Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects

Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects - Mydriatic Effects of Low Concentration Parasympatholytic Eye Drops in Normal Subjects

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054820

Enrollment

Registered

2024-06-29

Start date

2024-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal subjects

Interventions

Low concentration parasympatholytic eye drop once daily for 2 days Control drug administered 4 times daily for 2 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Informed consent Pupil diameter difference within 1mm Rocognize light reflex

Exclusion criteria

Exclusion criteria: History of serious disease History of eye surjery or eye trauma Use of drugs that affect the autonomic nervous system History of drug allergy Active eye disease Insufficient visual acuity Pregnant

Design outcomes

Primary

Measure	Time frame
Pupil diameter changes before and after using eye drops	—

Secondary

Measure	Time frame
NRS AE	—

Countries

Japan

Contacts

Public ContactKojiro Imai

Kyoto Prefectural University of Medicine Department for Medical Innovation and Translational Medical Science

kimai@koto.kpu-m.ac.jp075-251-5308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026